Hashimoto's thyroiditis as a risk factor for thyroid cancer

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Hashimoto's thyroiditis as a risk factor for thyroid cancer. / Feldt-Rasmussen, Ulla.

In: Current Opinion in Endocrinology, Diabetes and Obesity, Vol. 27, No. 5, 2020, p. 364-371.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Feldt-Rasmussen, U 2020, 'Hashimoto's thyroiditis as a risk factor for thyroid cancer', Current Opinion in Endocrinology, Diabetes and Obesity, vol. 27, no. 5, pp. 364-371. https://doi.org/10.1097/MED.0000000000000570

APA

Feldt-Rasmussen, U. (2020). Hashimoto's thyroiditis as a risk factor for thyroid cancer. Current Opinion in Endocrinology, Diabetes and Obesity, 27(5), 364-371. https://doi.org/10.1097/MED.0000000000000570

Vancouver

Feldt-Rasmussen U. Hashimoto's thyroiditis as a risk factor for thyroid cancer. Current Opinion in Endocrinology, Diabetes and Obesity. 2020;27(5):364-371. https://doi.org/10.1097/MED.0000000000000570

Author

Feldt-Rasmussen, Ulla. / Hashimoto's thyroiditis as a risk factor for thyroid cancer. In: Current Opinion in Endocrinology, Diabetes and Obesity. 2020 ; Vol. 27, No. 5. pp. 364-371.

Bibtex

@article{03ddc8b412b3478b8faa65a2866411cf,
title = "Hashimoto's thyroiditis as a risk factor for thyroid cancer",
abstract = "PURPOSE OF REVIEW: To summarize the recent developments in considering Hashimoto's thyroiditis as a risk factor for thyroid cancer. RECENT FINDINGS: Modern approaches to understanding the co-occurrence of Hashimoto's thyroiditis and thyroid cancer have consistently found increased prevalence of both conditions, separately as well as of their coexistence. The inflammatory process in Hashimoto's thyroiditis is understood as a potential risk factor for thyroid cancer development. This has also provided a better understanding of the limitations in the current diagnostic and follow-up armamentarium for both conditions, resulting in international guidelines from the clinical and scientific societies. Other recent developments call for a paradigm shift in guidelines on thyroid carcinomas when lymphocytic infiltration is present, which potentially should always be considered the case at least in areas of sufficient iodine intake. SUMMARY: The literature of Hashimoto's thyroiditis as a risk factor for thyroid cancer is reviewed over the last year to highlight new developments in the understanding of their association and future clinical implications.",
author = "Ulla Feldt-Rasmussen",
year = "2020",
doi = "10.1097/MED.0000000000000570",
language = "English",
volume = "27",
pages = "364--371",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "5",

}

RIS

TY - JOUR

T1 - Hashimoto's thyroiditis as a risk factor for thyroid cancer

AU - Feldt-Rasmussen, Ulla

PY - 2020

Y1 - 2020

N2 - PURPOSE OF REVIEW: To summarize the recent developments in considering Hashimoto's thyroiditis as a risk factor for thyroid cancer. RECENT FINDINGS: Modern approaches to understanding the co-occurrence of Hashimoto's thyroiditis and thyroid cancer have consistently found increased prevalence of both conditions, separately as well as of their coexistence. The inflammatory process in Hashimoto's thyroiditis is understood as a potential risk factor for thyroid cancer development. This has also provided a better understanding of the limitations in the current diagnostic and follow-up armamentarium for both conditions, resulting in international guidelines from the clinical and scientific societies. Other recent developments call for a paradigm shift in guidelines on thyroid carcinomas when lymphocytic infiltration is present, which potentially should always be considered the case at least in areas of sufficient iodine intake. SUMMARY: The literature of Hashimoto's thyroiditis as a risk factor for thyroid cancer is reviewed over the last year to highlight new developments in the understanding of their association and future clinical implications.

AB - PURPOSE OF REVIEW: To summarize the recent developments in considering Hashimoto's thyroiditis as a risk factor for thyroid cancer. RECENT FINDINGS: Modern approaches to understanding the co-occurrence of Hashimoto's thyroiditis and thyroid cancer have consistently found increased prevalence of both conditions, separately as well as of their coexistence. The inflammatory process in Hashimoto's thyroiditis is understood as a potential risk factor for thyroid cancer development. This has also provided a better understanding of the limitations in the current diagnostic and follow-up armamentarium for both conditions, resulting in international guidelines from the clinical and scientific societies. Other recent developments call for a paradigm shift in guidelines on thyroid carcinomas when lymphocytic infiltration is present, which potentially should always be considered the case at least in areas of sufficient iodine intake. SUMMARY: The literature of Hashimoto's thyroiditis as a risk factor for thyroid cancer is reviewed over the last year to highlight new developments in the understanding of their association and future clinical implications.

U2 - 10.1097/MED.0000000000000570

DO - 10.1097/MED.0000000000000570

M3 - Journal article

C2 - 32773575

AN - SCOPUS:85090508992

VL - 27

SP - 364

EP - 371

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 5

ER -

ID: 250380114